Brief: Prenetics' Act Genomics Receives FDA Clearance For Actonco
10/01/2023 11:11
Jan 10 (Reuters) - Prenetics Global Ltd PRE.O :
* PRENETICS OWNED ACT GENOMICS RECEIVES FDA CLEARANCE FOR
ACTONCO,
THE FIRST ASIA-BASED COMPANY TO RECEIVE CLEARANCE FOR A
COMPREHENSIVE GENOMIC PROFILING TEST FOR ALL SOLID TUMORS
* PRENETICS GLOBAL LTD: PRENETICS HAS COMPLETED MAJORITY
STAKE
ACQUISITION OF ACT GENOMICS
* PRENETICS GLOBAL LTD: CLEARANCE SETS STAGE FOR CONTINUED
RESEARCH AND DEVELOPMENT INVESTMENT INTO EARLY DETECTION /
LIQUID BIOPSY
Source text for Eikon: ID:nGNX2ry7Jn
Further company coverage: PRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prenetics Global
See all newsBrief: Prenetics’ Im8 Announces Two-Time Golden Globe-Nominated Actress And Producer Lily Collins As Im8 Global Ambassador And Shareholder In Multi-Year Partnership
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Prenetics Global Ltd reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics